Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Mar;43(3):419-428.
doi: 10.1007/s00134-016-4655-2. Epub 2016 Dec 27.

Venous thromboembolic events in critically ill traumatic brain injury patients

Markus B Skrifvars  1   2 , Michael Bailey  3 , Jeffrey Presneill  3   4 , Craig French  5   6 , Alistair Nichol  3   7   8 , Lorraine Little  3 , Jacques Duranteau  9 , Olivier Huet  10 , Samir Haddad  11 , Yaseen Arabi  11 , Colin McArthur  12 , D James Cooper  3   8 , Rinaldo Bellomo  3   13 ; EPO-TBI investigators and the ANZICS Clinical Trials Group
Affiliations
Randomized Controlled Trial

Venous thromboembolic events in critically ill traumatic brain injury patients

Markus B Skrifvars et al. Intensive Care Med. 2017 Mar.

Abstract

Purpose: To estimate the prevalence, risk factors, prophylactic treatment and impact on mortality for venous thromboembolism (VTE) in patients with moderate to severe traumatic brain injury (TBI) treated in the intensive care unit.

Methods: A post hoc analysis of the erythropoietin in traumatic brain injury (EPO-TBI) trial that included twice-weekly lower limb ultrasound screening. Venous thrombotic events were defined as ultrasound-proven proximal deep venous thrombosis (DVT) or clinically detected pulmonary embolism (PE). Results are reported as events, percentages or medians and interquartile range (IQR). Cox regression analysis was used to calculate adjusted hazard ratios (HR) with 95% confidence intervals (CI) for time to VTE and death.

Results: Of 603 patients, 119 (19.7%) developed VTE, mostly comprising DVT (102 patients, 16.9%) with a smaller number of PE events (24 patients, 4.0%). Median time to DVT diagnosis was 6 days (IQR 2-11) and to PE diagnosis 6.5 days (IQR 2-16.5). Mechanical prophylaxis (MP) was used in 91% of patients on day 1, 97% of patients on day 3 and 98% of patients on day 7. Pharmacological prophylaxis was given in 5% of patients on day 1, 30% of patients on day 3 and 57% of patients on day 7. Factors associated with time to VTE were age (HR per year 1.02, 95% CI 1.01-1.03), patient weight (HR per kg 1.01, 95% CI 1-1.02) and TBI severity according to the International Mission for Prognosis and Analysis of Clinical Trials risk of poor outcome (HR per 10% increase 1.12, 95% CI 1.01-1.25). The development of VTE was not associated with mortality (HR 0.92, 95% CI 0.51-1.65).

Conclusions: Despite mechanical and pharmacological prophylaxis, VTE occurs in one out of every five patients with TBI treated in the ICU. Higher age, greater weight and greater severity of TBI increase the risk. The development of VTE was not associated with excess mortality.

Keywords: Deep venous thrombosis; Erythropoietin; Pulmonary embolism; Traumatic brain injury; Venous thromboembolism.

PubMed Disclaimer

References

    1. N Engl J Med. 1994 Dec 15;331(24):1601-6 - PubMed
    1. Ann Surg. 2004 Sep;240(3):490-6; discussion 496-8 - PubMed
    1. Semin Intervent Radiol. 2010 Mar;27(1):68-80 - PubMed
    1. Circulation. 2008 Jan 1;117(1):93-102 - PubMed
    1. J Neurotrauma. 2007;24 Suppl 1:S32-6 - PubMed

Publication types

MeSH terms